{"id":30895,"date":"2025-02-14T10:29:31","date_gmt":"2025-02-14T09:29:31","guid":{"rendered":"https:\/\/www.cgfl.fr\/healthcare-professionals\/transversal-research\/registry\/"},"modified":"2025-10-08T13:54:59","modified_gmt":"2025-10-08T11:54:59","slug":"registry","status":"publish","type":"page","link":"https:\/\/www.cgfl.fr\/en\/healthcare-professionals\/transversal-research\/registry\/","title":{"rendered":"Registry"},"content":{"rendered":"\n
\n
\n

The C\u00f4te d\u2019Or Breast Cancer and Other Gynecological Cancers Registry.<\/h1>\n\n\n\n

The C\u00f4te d\u2019Or breast and other gynecological cancer registry was created in 1982. It continuously and exhaustively records information on the disease and all treatments provided for all new breast or pelvic cancers diagnosed in patients living in C\u00f4te d\u2019Or, regardless of the location of treatment. <\/p>\n\n\n\n

\n
The indicators <\/span><\/a><\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

Together, let’s overcome cancer.<\/strong><\/p>\n<\/div>\n\n\n\n

\"\"<\/figure>\n<\/section>\n\n
\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

The registry collaborates with all French registries (FRANCIM), INCa, Sant\u00e9 Publique France, the International Association of Cancer Registries (IACR) and the European Network of Cancer Registries (ENCR)<\/strong> for the epidemiological surveillance of gynecological cancers through the production of statistics on incidence, mortality and survival of cancers in France and worldwide by integrating data from the C\u00f4te d’Or department into the common database of cancer registries (hosted within the biostatistics department of the Hospices Civils de Lyon).<\/p>\n\n\n\n

Registries are the gold standard for epidemiological surveillance of cancers at the local, national, and international levels. Epidemiological indicators (incidence, prevalence, survival, and their trends), which are regularly produced from their data, make it possible to define, manage, and evaluate public policies to combat cancer (prevention, improvement of provision, quality of care, quality of life after cancer). <\/p>\n\n\n\n

The data from the C\u00f4te d\u2019Or Breast and other Gynecological Cancer Registry are extremely valuable and enable us to answer research questions and provide \u201creal-life\u201d data on the treatment of gynecological cancers.<\/p>\n\n\n\n

Due to the quality of its database and its age, the registry participates in numerous studies. It thus contributes to the evaluation of primary and secondary prevention actions (organized cancer screening), risk factors, diagnostic and therapeutic care of patients and the care needs of the general population. <\/p>\n\n\n\n

The registry was classified AAA (Means and Methods, Public Health Interest and Research Interest) by the Registry Evaluation Committee in March 2021 and ISO 9001 certified in April 2021.<\/em><\/strong><\/p>\n<\/div>\n<\/div>\n<\/section>\n\n

\n
\n

How it works<\/h2>\n\n\n
\n
\n

\n